title: REGARD: what can we learn from randomised, open-label, head-to-head studies?
authors.forename: Per Soelberg
authors.initials: PS
authors.lastname: Sørensen
mesh_terms: D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
chemical_list: D007155:Immunologic Factors